Cargando…
Identification of Long Noncoding RNAs lnc-DC in Plasma as a New Biomarker for Primary Sjögren's Syndrome
OBJECTIVE: To evaluate the plasma levels of lnc-DC in primary Sjögren's syndrome (pSS) patients and investigate the potential associations between lnc-DC and disease activity. METHODS: In this study, we recruited 358 enrollments, including 127 pSS patients without immune thrombocytopenia (ITP),...
Autores principales: | Chen, Yanhong, Chen, Yongqiang, Zu, Beibei, Liu, Jia, Sun, Li, Ding, Chen, Wang, Duping, Cheng, Xing, Yang, DeLiang, Niu, Guoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585659/ https://www.ncbi.nlm.nih.gov/pubmed/33123604 http://dx.doi.org/10.1155/2020/9236234 |
Ejemplares similares
-
LncRNAs, MALAT1 and lnc-DC as potential biomarkers for multiple sclerosis diagnosis
por: Shaker, Olfat G., et al.
Publicado: (2019) -
A potential prognostic biomarker SPC24 promotes tumorigenesis and metastasis in lung cancer
por: Zhou, Juan, et al.
Publicado: (2017) -
Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets
por: Min, Li, et al.
Publicado: (2017) -
Evaluation of circulating placenta-related long noncoding RNAs as potential biomarkers for preeclampsia
por: Wang, Xin, et al.
Publicado: (2018) -
Long noncoding RNAs (lncRNAs) in human lymphomas
por: Gholami, Ali, et al.
Publicado: (2021)